Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MIRA Pharmaceuticals Inc. Common Stock
MIRA | US
1.05
USD0
0%
MIRA | US
Loading StockChartView...
About MIRA Pharmaceuticals Inc. Common Stock
Sector
US
Industry
US
Earnings date
30/06/2024
As of date
24/04/2026
Close
1.05
Open
1.04
High
1.07
Low
1.02
View Less
MIRA | US
Risk
71.3
Sharpe
0.11
Luna's Score
34/100
Recommendation
Sell
Luna says (MIRA | US)
What's Working
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
55.1%1 month
71.3%3 months
78.4%6 months
66.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
8.06
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-1.45
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
17.08M
MarketCap(USD)
17.08M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-748.59
Short ratio
0.65
Short perc.
3.60
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.15
Range1M
0.20
Range3M
0.57
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.83
Price X volume
132.80K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.45 | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 8.06 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 78.36 | - | - |
| Debt to Equity | - | - | - |
| Debt to Assets | - | - | - |
| Market Cap | 17.08M | - | - |
